WESTFORD, Mass., Feb. 4, 2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that Chairman and Chief Executive Officer Michael Davin and Tim Baker, the Company's President and Chief Financial Officer, will participate in the LEERINK Partners 5th Annual Global Healthcare Conference in New York City.
The event, which will be conducted in a "fireside chat" format, is scheduled for 8:55 a.m. (ET) Thursday, February 11. Both live and archived audio webcasts of the event will be accessible through a link on the Investors section of the Company's website, www.cynosure.com.
About Cynosure, Inc. Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health. Cynosure also markets radiofrequency energy sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd:YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and radiofrequency technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.
Contact: Scott Solomon Senior Vice President Sharon Merrill Associates, Inc. 617.542.5300 firstname.lastname@example.org
SOURCE Cynosure, Inc.